fbpx

Research

QLUCORE: Streamlining focus to extend financial runway

Analys, Research

In Q1’23/24, both sales of Qlucore Omics Explorer and costs were slightly higher than we expected. To extend its runway, Qlucore will...

Read More

GRANGEX: Steep acceleration towards two permitted CO2-free iron ore projects

Analys, Research

GRÄNGESBERG EXPLORATION 2023 has proven a pivotal year for GRANGEX. Soon after the environmental court’s approval to restart...

Read More

CRUNCHFISH: Mixed picture in India with a rights issue pressing closer

Analys, Research

In June, Crunchfish signed its first breakthrough commercial order for Digital Cash Offline, with Indian IDFC Bank. But the Q2 report left...

Read More

EfTEN: Winner in a downturn

Analys, Research

RESEARCH COLLABORATION WITH ENLIGHT RESEARCH Attractive entry and running yields supported by rent increases enable EfTEN Real Estate Fund...

Read More

MOTION DISPLAY: Sales strength signals promising future

Analys, Research

The strong start to 2023 has now made its mark in the books, with the revenues to date already surpassing sales in the full year 2022. With...

Read More

KEBNI: Soft Q2 ahead of ramp-up in H2’23-2026

Analys, Research

Sales in Q2’23 of SEK 7.4m were softer than we expected. While we are optimistic about a significant increase in sales in H2’23...

Read More

NANEXA: Progress with NEX-20 and NEX-22 Amid Rising GLP-1 Interest

Analys, Research

Nanexa’s Q2’23 advancements with NEX-20 and NEX-22 underscore the company’s forward momentum. NEX-20 is set to provide a more...

Read More

AGTIRA: Agtira Greens ready for take-off

Analys, Research

The Q2 report was pretty much in line with our expectations, apart from a slight miss on sales due to replanting efforts. The partnership...

Read More

KEBNI: Financing and second volume order clear path for sales surge in 2023-2026

Analys, Research

Late Wednesday evening KebNi announced that it has raised SEK 29.6m from a group of professional investors, including the two largest of...

Read More

BONZUN: Merger with L2S a favorable reconfiguration for Bonzun’s shareholders

Research

Bonzun has agreed to sell all shares in its subsidiary Bonzun Evolve to CBT-based sleep therapy company Learning to Sleep (L2S, listed on...

Read More

For new research on growth stocks, sign up to our newsletter